Table 1 Baseline clinical characteristics of patients
Clinical characteristic | Prognosis analysis in gliomas | Prognosis analysis in LGG | Prognosis analysis in GBM |
|---|---|---|---|
NO. of patients | 975 | 414 | 561 |
Age (years) | |||
 ≥55 | 546 | 326 | 220 |
 <55 | 429 | 88 | 341 |
Gender | |||
 Male | 573 | 227 | 346 |
 Female | 402 | 187 | 215 |
WHO grade | |||
 II | 198 | 198 | 0 |
 III | 216 | 216 | 0 |
 IV | 561 | 0 | 561 |
IDH status | |||
 Wild | 483 | 77 |  |
 Mutant | 372 | 337 | |
 Undefined | 120 | 2 | |
MGMT status | |||
 Unmethylated | 280 |  | 211 |
 Methylated | 514 | 169 | |
 Undefined | 181 | 181 | |